Brodalumab: Seven-Year US Pharmacovigilance Report

By afschroeder • July 30, 2025

Lebwohl MG, Koo JY, Armstrong AW, Strober BE, Yoon SH, Rawnsley NN, Goehring EL Jr, Jacobson AA. Brodalumab: Seven-Year US Pharmacovigilance Report. Dermatol Ther (Heidelb). 2025 Jul 29. doi: 10.1007/s13555-025-01497-w. Epub ahead of print. PMID: 40730908.

Tags: Adverse events, Dermatology, Drug reaction, psoriasis, Publications, real-world, safety

To Treat or Not to Treat: Two Roads Traveled With Alopecia Areata

Taghizadeh CS, Goh C. To Treat or Not to Treat: Two Roads Traveled With Alopecia Areata. Pediatr Dermatol. 2025 Aug 15. doi: 10.1111/pde.70006. Epub ahead[...]

Overcoming ovarian cancer resistance and evasion to CAR-T cell therapy by harnessing allogeneic CAR-NKT cells

Li YR, Li Z, Zhu Y, Li M, Chen Y, Lee D, Ochoa CJ, Singh T, DiBernardo G, Guo W, Li S, Zhou Y, Yu[...]

Dopamine signaling drives skin invasion by human-infective nematodes

Patel R, Bartolo G, Castelletto ML, Garcia Romero A, Bryant AS, Agak GW, Hallem EA. Dopamine signaling drives skin invasion by human-infective nematodes. Nat Commun.[...]